Blood DNA methylation pattern is altered in mesial temporal lobe epilepsy

Hong-Yu Long1, Li Feng1, Jin Kang1

  • 1Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.

Scientific Reports
|March 10, 2017
PubMed

Insights

Peripheral epigenetic changes, specifically DNA methylation patterns in blood, are significantly altered in Mesial Temporal Lobe Epilepsy (MTLE) patients compared to controls. These epigenetic alterations may play a role in disease mechanisms and warrant further investigation.

Area of Science:

  • Epigenetics
  • Neuroscience
  • Genomics

Background:

  • Mesial temporal lobe epilepsy (MTLE) is a prevalent neurological disorder.
  • The association between MTLE and peripheral epigenetic modifications remains largely unexplored.

Purpose of the Study:

  • To investigate whole-genome DNA methylation patterns in the blood of MTLE patients.
  • To identify differentially methylated genes and pathways in MTLE.
  • To explore correlations between epigenetic changes and clinical features of MTLE.

Main Methods:

  • Human Methylation 450K BeadChip assay was used to compare DNA methylation in 30 MTLE patients and 30 controls.
  • Bioinformatics profiling was employed to analyze differentially methylated genes and pathways.

Main Results:

  • Significant differences in DNA methylation were observed at 216 sites between MTLE patients and controls (P < 1.03e-07).
  • 164 sites showed hypermethylation and 52 showed hypomethylation, primarily in coding regions and promoters.
  • Differentially methylated genes are linked to pathways involved in anion binding, oxidoreductant activity, growth regulation, skeletal development, and drug metabolism.

Conclusions:

  • Peripheral epigenetic alterations are evident in MTLE patients.
  • These changes may contribute to disease pathogenesis and could serve as potential biomarkers.
  • Further translational research is recommended to explore the clinical implications of these findings.